FDA green lights Oxehealth vital signs monitoring software
pharmaphorum
APRIL 6, 2021
In a clinical trial, the software was found to be accurate to within three beats per minute for pulse rate compared to contact pulse oximeters, and two breaths per minute for estimated breathing rate. The approval means the Oxford University spin-out can place Oxevision on the market in all US states.
59 
Let's personalize your content